Clinical trials
Completed Musculoskeletal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
411 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 13 |
| 2010 | 4 |
| 2011 | 10 |
| 2012 | 10 |
| 2013 | 18 |
| 2014 | 23 |
| 2015 | 20 |
| 2016 | 22 |
| 2017 | 28 |
| 2018 | 37 |
| 2019 | 27 |
| 2020 | 25 |
| 2021 | 45 |
| 2022 | 33 |
| 2023 | 30 |
| 2024 | 20 |
| 2025 | 15 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 411 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 12 |
| National Research Centre for the Working Environment, Denmark | 11 |
| Afyonkarahisar Health Sciences University | 8 |
| Amgen | 5 |
| Chinese University of Hong Kong | 5 |
| I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 5 |
| University of Pittsburgh | 5 |
| Regeneron Pharmaceuticals | 4 |
| Rigshospitalet, Denmark | 4 |
| Vanderbilt University Medical Center | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Musculoskeletal Diseases | 411 |
| Joint Diseases | 60 |
| Arthritis | 45 |
| Osteoarthritis | 33 |
| Rheumatic Diseases | 30 |
| Pain | 24 |
| Osteoarthritis, Knee | 22 |
| Bone Diseases | 21 |
| Nervous System Diseases | 19 |
| Arthritis, Rheumatoid | 18 |
Trials
Showing 1 to 25 of 411. Each trial links to its page on Pharma Observatory.
311 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.